Haplo-BMT: Which approach?

Blood

Volumn 121, Issue 5, 2013, Pages 719-720

  Velardi, Andrea ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA ANTIGEN; METHOTREXATE; MINOR HISTOCOMPATIBILITY ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; BONE MARROW TRANSPLANTATION; DRUG MEGADOSE; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HAPLOTYPE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOREGULATION; MYELOABLATIVE CONDITIONING; NATURAL KILLER CELL; PRIORITY JOURNAL; SHORT SURVEY; T CELL DEPLETION;

EID: 84873532382     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-12-469981     Document Type: Short Survey

References (9)

1. Di Bartolomeo P, Santarone S, De Angelis G, et al. Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies. Blood. 2013;121(5):849-857.
2. Reisner Y, Hagin D, Martelli MF. Haploidentical hematopoietic transplantation: current status and future perspectives. Blood. 2011;118(23):6006-6017.
3. Aversa F, Tabilio A, Velardi A, et al. Treatment of highrisk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplo type. NEngl J Med. 1998;339(17):1186-1193. (Pubitemid 28482127)
4. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100. (Pubitemid 34229476)
5. Di Ianni M, Falzetti F, Carotti A, et al. Tregs prevent GVHDand promote immune reconstitution in HLA haploidentical transplantation. Blood. 2011;117(14):3921-3928.
6. Fuchs EJ. Human leukocyte antigen-haploidentical stem cell transplantation using T-cell-replete bone marrow grafts. Curr Opin Hematol. 2012;19(6):440-447.
7. Ciceri F, Bregni M, Peccatori J. Innovative platforms for haploidentical stem cell transplantation: the role of unmanipulated donor graft. J Cancer. 2011;2:339-340.
8. Huang X-J, Liu D-H, Liu K-Y, et al. Treatment of acute leukemia with unmanipulated HLA mismatched/haploidentical blood and bone marrow transplantation. Biol Blood Marrow Transplant. 2009;15(2):257-265.
9. Raiola AM, Dominietto A, Ghiso A, et al. Unmanipulated haploidentical bone Marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning. Biol Blood Marrow Transplant. 2012;pii:S1083-8791(12)00348-5.